Buenos Aires, Argentina

Buenos Aires Macula

Meningitis

Meningococcal Meningitis

Macular Degeneration

Meningococcal Infections

Novartis

OcuDyne

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

Feasibility of the OcuDyne OPTiC System in patients with late-stage non-exudative age-related macular degeneration.

OcuDyne System in the Treatment of AMD

Buenos Aires Macula | Buenos Aires, Argentina

Site insights

Work at this site?

Active trials

OcuDyne System in the Treatment of AMD

Trial sponsors